(Q62110906)

English

Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum

clinical trial

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

A Phase II Trial of Paclitaxel (Taxol) Administered as a Weekly One Hour Infusion in Patients With Taxol/Platinum-Refractory Stage III and IV Ovarian Cancer (English)

0 references

sponsor

Theradex (United States)

0 references

country

United States of America

0 references

start time

September 1997

0 references

number of participants

100

0 references

research intervention

paclitaxel

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Carolinas Medical Center

0 references

Harrington Cancer Center

0 references

Akron General Medical Center

0 references

research subject recruitment status

unknown

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00003160

0 references

(Q62110906)

Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)